Policy / Pricing Medicare obesity drug pilot extended after insurer pushback PharmaphorumMedicare will cover the cost of a pilot of weight-loss drug coverage, after health insurers refuse to take part.Policy / PricingMetabolic & GLP-1Read full story pharminent April 22, 2026 (Last updated: April 22, 2026) Pharmaphorum Medicare will cover the cost of a pilot of weight-loss drug coverage, after health insurers refuse to take part. Policy / PricingMetabolic & GLP-1Read full story Post navigation Previous: Health Canada approves Biocon’s two denosumab biosimilarsNext: BioAegis and Prenosis partner for inflammatory disease therapies Related Stories Policy / Pricing UniQure, Replimune shares rise as FDA’s Makary exits, but path forward unchanged pharminent May 13, 2026 Policy / Pricing EU agrees plan to tackle essential medicine shortages pharminent May 12, 2026 Policy / Pricing 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders (NEW Live Video Webinar) pharminent May 12, 2026
